tree top health semaglutide Blue Store - Treetop Health 2

Circulation 129 (25 Suppl 2), S102S138 (2014)

Prior authorization is common, and in some cases, insurers require documented evidence of other weight loss programs being tried and failed first

Discontinue promptly if suspected and avoid re-exposure to exenatide Serious Injection-Site Reactions (eg, abscess, cellulitis, and necrosis), with or without subcutaneous nodules, have been reported Acute Gallbladder Disease has been reported in GLP-1 receptor agonist trials, including exenatide

About this Guide This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals